Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Laureate Education
LAUR
$5.44B
| $1.4M | ﹤0.01% |
140,100
-414,200
| -75% | -$4.01M |
2020 Q1
1 quarter
|
|
|
APTS
2377
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.39M | ﹤0.01% |
+183,400
| New | +$1.33M |
2020 Q2
0 quarters
|
|
2378
Sprout Social
SPT
$667M
| $1.39M | ﹤0.01% |
+51,600
| New | +$1.13M |
2020 Q2
0 quarters
|
|
2379
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $1.39M | ﹤0.01% |
248,089
+30,347
| +14% | +$181K |
2013 Q2
28 quarters
|
|
2380
Hudson Pacific Properties
HPP
$650M
| $1.39M | ﹤0.01% |
7,886
-187,543
| -96% | -$31.9M |
2017 Q4
10 quarters
|
|
2381
Grifois
GRFS
$5.08B
| $1.39M | ﹤0.01% |
76,107
-246,928
| -76% | -$4.9M |
2017 Q1
13 quarters
|
|
2382
Happen Inc
HAPN
$1.75B
| $1.39M | ﹤0.01% |
+305,120
| New | +$1.9M |
2020 Q2
0 quarters
|
|
2383
Oil States International
OIS
$493M
| $1.38M | ﹤0.01% |
290,743
-115,757
| -28% | -$445K |
2018 Q4
6 quarters
|
|
2384
Freeport-McMoran
FCX
$106B
| $1.38M | ﹤0.01% |
+119,071
| New | +$1.09M |
2020 Q2
0 quarters
|
|
2385
iShares Core Moderate Allocation ETF
AOM
$1.94B
| $1.38M | ﹤0.01% |
34,500
+26,000
| +306% | +$1M |
2019 Q2
4 quarters
|
|
2386
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.38M | ﹤0.01% |
+39,500
| New | +$1.11M |
2020 Q2
0 quarters
|
|
2387
Enlivex Ltd
ENLV
$5.06M
| $1.38M | ﹤0.01% |
18,114
+11,781
| +186% | +$945K |
2016 Q2
16 quarters
|
|
|
BLCM
2388
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.38M | ﹤0.01% |
185,071
-39,300
| -18% | -$267K |
2018 Q4
6 quarters
|
|
2389
NextCure
NXTC
$32.9M
| $1.37M | ﹤0.01% |
+5,342
| New | +$2.03M |
2020 Q2
0 quarters
|
|
|
PRAH
2390
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.37M | ﹤0.01% |
+14,100
| New | +$1.31M |
2020 Q2
0 quarters
|
|
|
SPRT
2391
DELISTED
support.com, Inc.
SPRT
| $1.37M | ﹤0.01% |
972,424
-37,706
| -4% | -$50K |
2013 Q2
28 quarters
|
|
2392
Q32 Bio
QTTB
$248M
| $1.37M | ﹤0.01% |
5,011
+2,023
| +68% | +$539K |
2020 Q1
1 quarter
|
|
|
CDOR
2393
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $1.37M | ﹤0.01% |
334,196
+6,609
| +2% | +$25.5K |
2017 Q3
11 quarters
|
|
|
NEW
2394
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
| $1.37M | ﹤0.01% |
26,485
+8,433
| +47% | +$474K |
2019 Q3
3 quarters
|
|
2395
Vanguard Information Technology ETF
VGT
$157B
| $1.37M | ﹤0.01% |
+39,200
| New | +$1.22M |
2020 Q2
0 quarters
|
|
2396
NWPX Infrastructure Inc
NWPX
$976M
| $1.36M | ﹤0.01% |
54,400
+21,700
| +66% | +$516K |
2015 Q2
20 quarters
|
|
2397
Nicolet Bankshares
NIC
$3.41B
| $1.36M | ﹤0.01% |
24,795
-23,200
| -48% | -$1.25M |
2017 Q1
13 quarters
|
|
2398
Innodata
INOD
$2.13B
| $1.36M | ﹤0.01% |
1,014,930
+61,593
| +6% | +$70.8K |
2013 Q2
28 quarters
|
|
2399
DELISTED
Provident Bancorp
PVBC
| $1.36M | ﹤0.01% |
172,653
+22,100
| +15% | +$191K |
2019 Q3
3 quarters
|
|
2400
CB Financial Services
CBFV
$189M
| $1.36M | ﹤0.01% |
62,165
+2,167
| +4% | +$48.4K |
2018 Q2
8 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.